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We previously reported that persistent application of the non-specific cholinergic agonist
carbachol (CAR) increased the frequency of calcium channel-mediated oscillatory activ-
ity in pedunculopontine nucleus (PPN) neurons, which we identified as dependent on
voltage-gated, high-threshold P/Q-type channels. Here, we tested the hypothesis that M2
muscarinic receptors and G-proteins associated with M2 receptors mediate the increase
in oscillatory frequency in PPN neurons. We found, using depolarizing ramps, that patch
clamped 9–12 day old rat PPN neurons (n=189) reached their peak oscillatory activity
around−20 mV membrane potential. Acute (short duration) application of CAR blocked the
oscillatory activity through M2 muscarinic receptors, an effect blocked by atropine. How-
ever, persistent (long duration) application of CAR significantly increased the frequency of
oscillatory activity in PPN neurons through M2 receptors [40±1 Hz (with CAR) vs. 23±1 Hz
(without CAR); p<0.001]. We then tested the effects of the G-protein antagonist guano-
sine 5′-[β-thio] diphosphate trilithium salt (GDP-β-S), and the G-protein agonist 5′-[γ-thio]
triphosphate trilithium salt (GTP-γ-S). We found, using a three-step protocol in voltage-
clamp mode, that the increase in the frequency of oscillations induced by M2 cholinergic
receptors was linked to a voltage-dependent G-protein mechanism. In summary, these
results suggest that persistent cholinergic input creates a permissive activation state in the
PPN that allows high frequency P/Q-type calcium channel-mediated gamma oscillations to
occur.
Keywords: calcium channels, carbachol, gamma oscillations, G-proteins, muscarinic receptors, 5′-[β-thio] diphos-
phate trilithium salt, 5′-[γ-thio] triphosphate trilithium salt
INTRODUCTION
The pedunculopontine nucleus (PPN) is part of the reticular acti-
vating system (RAS), which modulates the fast oscillating rhythms
between thalamus and cortex manifested in the EEG during the
activated states of waking and rapid eye movement (REM) sleep
(1). The PPN is located ventral to the inferior colliculus and
partially embedded in the lateral portion of the superior cere-
bellar peduncle. We found that all PPN cell types maximally
fire at gamma frequency (2), and exhibit intrinsic oscillatory
beta/gamma band frequency (20–29 Hz/30–80 Hz, respectively)
activity dependent on high threshold,voltage-dependent P/Q-type
calcium channels, which can be modulated by carbachol [CAR;
Ref. (3)]. The present study was undertaken to determine the
mechanism behind the modulation of high frequency oscillatory
activity of individual PPN neurons by CAR.
The PPN receives cholinergic input from the contralateral
PPN and laterodorsal tegmental nuclei (4). Muscarinic receptors
(mAChR) have five subtypes M1–M5. M2 and M4 receptors are
known to be Gi-protein coupled. These receptors increase the
membrane conductance to potassium ions while reducing cal-
cium currents, which hyperpolarizes the membrane potential (5).
M1, M3, and M5 receptors are thought to be excitatory, and are
linked to Gq proteins. Activation of M1 receptors will depolarize
the membrane potential by blocking potassium currents (6), prob-
ably through the intracellular calcium signaling pathway mediated
by inositol 1,4,5-triphosphate. Previous studies showed that PPN
cholinergic neurons were predominantly hyperpolarized by the
activation of post-synaptic M2 receptors (7, 8). Different in situ
hybridization studies confirmed that cholinergic cells in the PPN
primarily express M2 receptors, although low levels of M3 and M4
mRNA have been detected (9, 10). Previous studies from our lab-
oratory showed that 73% of PPN output neurons were inhibited
through M2 receptors, 13% were excited through M1 and nicotinic
receptors, and 7% showed biphasic responses (11).
G-protein inhibition of both N- and P/Q-type calcium chan-
nels by CAR has been extensively characterized in previous stud-
ies (12–16). Both voltage-dependent and voltage-independent
G-protein pathways that inhibit calcium channels have been
described in a number of systems (17). Voltage-dependent modu-
lation is initiated by G-protein activation and mediated by the
Gβγ subunit (14, 15). When the membrane potential is dri-
ven to positive voltages, this shift can be partially reversed.
On the contrary, other G-protein mediated pathways block cal-
cium channels by mechanisms insensitive to membrane potential
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(i.e., voltage-independent), and have been described as pertussis
toxin-insensitive G-proteins (14, 16, 17).
Although the dependence of PPN oscillations on P/Q-type
calcium channels has been established (3), modulation of this
activity by cholinergic input and its G-protein-dependent mecha-
nism is poorly understood. In this study, we found that direct and
voltage-independent modulation of P/Q-type calcium channels
by G-protein mediated intracellular pathways underlies the effects
of CAR on gamma frequency activity in the PPN.
MATERIALS AND METHODS
SLICE PREPARATION
Rat pups aged 9–12 days from adult timed-pregnant Sprague-
Dawley rats (280–350 g) were anesthetized with ketamine
(70 mg/kg, i.m.) until the tail pinch reflex was absent. This age
range was selected due to the developmental decrease in REM
sleep in the rat that occurs between 10 and 30 days (18). In addi-
tion, it is well known that most of the changes in PPN transmitter
interactions occur across the 12–16 day period [reviewed in Ref.
(19)]. This window of investigation enabled sampling from a base-
line period before the epoch of the greatest transitions that peak
at 12–16 days and continues until∼20 days, as determined by our
previous body of work on the PPN (19). However, we did not
observe either age-related (9–12 days) or cell type related changes
in the properties described below, in agreement with our pre-
vious work (3). Pups were decapitated and the brain was rapidly
removed and cooled in oxygenated sucrose-artificial cerebrospinal
fluid (sucrose-aCSF). The sucrose-aCSF consisted of (in millimo-
lar): 233.7 sucrose, 26 NaHCO3, 3 KCl, 8 MgCl2, 0.5 CaCl2,
20 glucose, 0.4 ascorbic acid, and 2 sodium pyruvate. Sagittal
sections (400µm) containing the PPN were cut and slices were
allowed to equilibrate in normal aCSF at room temperature for
1 h before recording. The aCSF was composed of (in millimo-
lar): 117 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2 NaH2PO4,
24.9 NaHCO3, and 11.5 glucose. Slices were recorded at 37°C
while perfused (1.5 ml/min) with oxygenated aCSF (95% O2−
5% CO2) in an immersion chamber containing the sodium chan-
nel blocker tetrodotoxin citrate (TTX, 3µM), and the following
neurotransmitter receptor antagonists: the selective NMDA recep-
tor antagonist 2-amino-5-phosphonovaleric acid (APV, 40µM),
the competitive AMPA/kainate receptor antagonist 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX, 10µM), the glycine receptor
antagonist strychnine (STR, 10µM), and the specific GABAA
receptor antagonist gabazine (GBZ, 10µM), all purchased from
Sigma-Aldrich (St. Louis, MO, USA). Our experimental protocols
were approved by the Institutional Animal Care and Use Commit-
tee of the University of Arkansas for Medical Sciences, and were
in agreement with the National Institutes of Health guidelines for
the care and use of laboratory animals.
WHOLE-CELL PATCH CLAMP RECORDINGS
Differential interference contrast optics was used to visualize neu-
rons using an upright microscope (Nikon FN-1, Nikon, Japan).
Whole-cell recordings were performed using borosilicate capil-
lary glass tubing pulled on a P-1000 puller (Sutter Instrument
Company, Novato, CA, USA). Electrodes were filled with high-K+
intracellular solution (in millimolar): 130 K+-methanesulfonate,
10 NaCl, 10 Phosphocreatine, 10 HEPES, 1 EGTA, 4 Mg-ATP,
0.4 Na2GTP, 2 MgCl2, 10 sucrose. To study calcium currents,
electrodes were filled with high-Cs+/QX-314 intracellular solu-
tion (in millimolar): 110 Cs+-methanesulfonate, 40 HEPES, 1
EGTA, 5 QX-314, 10 TEA-Cl, 4 Mg-ATP, 0.4 Na2GTP, 10 Phos-
phocreatine, 2 MgCl2. Cesium is a widely used potassium chan-
nel blocker, while QX-314 (Sigma-Aldrich, St. Louis, MO, USA)
blocks sodium channels intracellularly. Osmolarity was adjusted
to ∼270–290 mOsm/L and pH to 7.3. The pipette resistance was
2–4 MΩ. All recordings were made using a Multiclamp 700B
amplifier (Molecular Devices, Sunnyvale, CA, USA). Data was
recorded in both current and voltage-clamp modes. Analog sig-
nals were low-pass filtered at 2 kHz, and digitized at 5 kHz using
a Digidata-1440A interface and pClamp10 software (Molecular
Devices). The recording region was located mainly in the pars
compacta in the posterior PPN, immediately dorsal to the supe-
rior cerebellar peduncle. This area of the PPN has been shown
to have the highest density of cells (11, 20). Gigaseal and further
access to the intracellular neuronal compartment was achieved in
voltage-clamp mode, a series of hyperpolarizing steps run to iden-
tify cell type, followed by setting the holding potential at−50 mV
[which is close to the average resting membrane potential of PPN
neurons and also inactivates T-type calcium channels, (3)]. Soon
after rupturing the membrane, the intracellular solution reached
equilibrium with the pipette solution without significant changes
in either series resistance or membrane capacitance values. The
configuration was then changed to current-clamp mode, another
series of steps were run to confirm cell type, and the membrane
potential was then depolarized using either 1 s (3) or 30 s depo-
larizing current ramp protocols, allowing the assessment of longer
periods of high frequency oscillatory activity in PPN neurons. Pre-
vious studies have shown that there are three major cell types in the
PPN which manifest (a) low threshold spikes (LTS) upon release
from hyperpolarization (type I), which are non-cholinergic, (b)
Ia current that slows the return from release from hyperpolariza-
tion (type II), two-thirds of which are cholinergic, and (c) both
Ia and LTS, one third of which are cholinergic [reviewed in Ref.
(1, 19)]. All the cells analyzed in this research were type I, II, or
III. Calcium channel-mediated oscillatory activity in PPN neurons
was studied in current-clamp mode, in the presence of synaptic
blockers (see above) and TTX. Previous studies showed that all
PPN cell types manifest calcium channel-mediated gamma band
activity, and that the only difference is that type II cells showed
lower amplitude gamma oscillations than type I and III PPN cells
(3). Calcium currents were studied using the high-Cs+/QX-314
pipette solution also in the presence of synaptic blockers and TTX
at a holding potential of−50 mV. Time course of activation (τON)
and deactivation (τOFF) of calcium currents were obtained after fit-
ting individual currents to the function y = y0+ a× exp (−Time
(ms)/τ(ON or OFF)). No significant rundown due to intracellular
dialysis of PPN neuronal activity was observed (up to 30 min)
using these methods. Membrane voltage was depolarized from the
−50 mV holding potential after compensating series resistance
(after compensation, final Rs values ranged 5–10 MΩ; >12 kHz
bandwidth). Three-pulse square voltage steps (consisting of a test
pulse to 0 mV, or pre-pulse, for 20 ms followed by a strong depo-
larizing step to +50 mV for 20 ms, a brief return to the holding
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potential of −50 mV for 10 ms, followed by another test pulse to
0 mV, or post-pulse for 20 ms, durations designed to allow full
recovery of high threshold, voltage-dependent calcium currents)
were used to study G-protein modulation of PPN calcium cur-
rents by CAR (12–16). This protocol allowed us to characterize
whether G-protein inhibition of calcium currents was mediated
by a voltage-dependent (i.e., when CAR inhibition was less potent
during the post-pulse than during the pre-pulse), or by a voltage-
independent pathway (i.e., when a similar inhibition by CAR was
observed during both pre- and post-pulses). After determining
cell type, we tested the control responses to depolarizing ramps,
namely the induction of gamma band oscillations. The effects
of acute application of CAR (30µM) then were recorded over
the first 10 min of perfusion, during which ramps were applied
every minute. On the other hand, the persistent effect of CAR
was quantified in an extracellular solution containing the synaptic
blockers, nicotinic antagonists, and CAR (30µM) applied contin-
uously for 20 min or longer before current ramps were applied to
elicit oscillations.
DRUG APPLICATION
Bath-applied drugs were administered to the slice via a peri-
staltic pump (Cole-Parmer, Vernon Hills, IL, USA) and a three-
way valve system such that drugs reached the slice in 1.5 min.
The sodium channel blocker tetrodotoxin citrate (TTX, 3µM)
was purchased from Sigma-Aldrich (St. Louis, MO, USA), as
well as cholinergic agonist carbachol (CAR, 30µM). Choliner-
gic antagonists were also purchased from Sigma, mecamylamine
(MEC, 10µM, a nicotinic receptor antagonist), methoctramine
(MTO, 2µM, a M2 muscarinic receptor antagonist), pirenzepine
(PIR, 10µM, a M1 muscarinic receptor antagonist), and atropine
(ATR, 10µM, a non-specific muscarinic receptor antagonist) to
confirm the receptor type responsible for the changes in oscil-
latory frequency in PPN neurons. The calcium channel blockers
were purchased from Alomone labs (Alomone.com). We used ω-
conotoxin-GVIA (ω-CgTX, 2.5µM, applied >20 min), a specific
N-type calcium channel blocker, to confirm the effects of CAR
on P/Q-type calcium channels. Both ω-CgTX and ω-agatoxin-
IVA (ω-AgA, 100–200 nM, applied >20 min) were used to con-
firm that both beta/gamma oscillations and calcium currents
recorded from PPN neurons were P/Q- and N-type calcium chan-
nel mediated (3). The G-protein antagonist guanosine 5′-[β-thio]
diphosphate trilithium salt (GDP-β-S, 1 mM), and the G-protein
agonist guanosine 5′-[γ-thio] triphosphate trilithium salt (GTP-
γ-S, 0.4 mM) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). GDP-β-S and GTP-γ-S were administered intracellularly
through the recording micropipette.
DATA ANALYSIS
Off-line analyses were performed using Clampfit software (Molec-
ular Devices, Sunnyvale, CA, USA). Comparisons between groups
were carried out using either Student’s t -test or one-way ANOVA,
with Bonferroni correction of post hoc testing for multiple com-
parisons. A repeated-measures ANOVA model was fit for each
response using SAS Proc Mixed software (SAS Institute Inc., Cary,
NC, USA), and the Bonferroni or Dunn’s post hoc tests were further
calculated. t -Values and degrees of freedom were reported for all
linear regression ANOVAs. Differences were considered significant
at values of p≤ 0.05. All results are presented as mean± SEM.
RESULTS
Whole-cell patch clamp recordings were performed from a total
of 189 PPN neurons and their responses to depolarizing 1 s and
30 s current ramps showed voltage dependence of their oscillatory
behavior as previously described (3). The neurons were localized
mainly in the pars compacta of the posterior PPN, which is eas-
ily identified in sagittal sections of the brainstem (Figure 1D)
(2, 3, 11). In this study, we recorded from 32 type I, 92 type II,
and 65 type III PPN cells. We previously showed that, regardless
of cell type, P/Q-type calcium channel activation mediated oscil-
latory activity in PPN neurons (3). Moreover, we reported that
continuous, long duration application of CAR (30µM) increased
the frequency of these oscillations (3). Previous studies described
the proportion of mesopontine cells responding to short duration
exposure to cholinergic agents. Over 89% of cells in the PPN and
LDT of the guinea pig (8), and 95% of rat LDT neurons (7) were
hyperpolarized by CAR. We used low levels of current to com-
pensate CAR-mediated changes in membrane potential in order
to maintain Vm in the −50 mV range, as previously reported (3).
After studying both the acute and persistent effects of CAR on
oscillatory activity in PPN neurons, we undertook pharmacolog-
ical characterization of the cholinergic receptors responsible for
the increase in frequency. Finally, we ascertained the role of G-
proteins in the increase in oscillatory frequency induced by CAR,
and their association with high-threshold voltage-gated P/Q-type
calcium channels.
One of the main characteristics of PPN oscillations is that
the membrane potential has to be gradually depolarized up to
∼−20 mV (using 1 s current ramps) in order to activate high
threshold, voltage-dependent P/Q-type calcium channels, and to
a lesser extent, N-type calcium channels, that mediate high fre-
quency oscillations. Calcium imaging techniques confirmed that
these oscillations are indeed occurring in the dendrites of the
PPN neurons (21). Although we cannot determine the actual
membrane potential of the dendrites without clamping them,
we assume that, due to the accumulated membrane capacitance
between the electrode and the dendritic compartments, the real
threshold of these oscillations is much closer to physiological
values and close to action potential (AP) threshold. Represen-
tative membrane potential oscillations were recorded using 1 s
current ramps (using >300 pA current amplitudes). PPN oscil-
lation amplitudes peaked at around −20 mV and progressively
diminished when the membrane potential was depolarized above
−10 mV (Figure 1A). A similar result was observed in 29 PPN
neurons. We attempted to diminish the decrease in oscillation
amplitude by depolarizing membrane potential in a more gradual
fashion. We used longer, 30 s ramps (data not shown), achieving a
more gradual depolarization that allowed us to detect oscillatory
activity at around −40 mV membrane potential (a similar effect
was observed in 25 PPN neurons). In addition, lower current lev-
els (100–300 pA) were needed to reach the −20 mV threshold for
the peak of the oscillations. Longer duration ramps, therefore,
allowed us to increase the number of points sampled at different
membrane potentials manifesting a similar pattern of frequencies
www.frontiersin.org November 2013 | Volume 4 | Article 176 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kezunovic et al. Modulation of high frequency in the PPN
FIGURE 1 | Acute vs. persistent effect of CAR on the oscillatory
behavior of PPN neurons. (A) Representative 1 s long current
ramp-induced oscillations of a PPN neuron in SB+TTX+MEC extracellular
solution (left record, black). After 3 min of CAR in the extracellular solution,
the oscillatory activity diminished (middle record, red). However, the acute
effect of CAR on oscillations was reversed by adding ATR to the solution
(after 3 min of perfusion with a solution containing CAR+ATR) (right
record, blue). (B) Representative 1 s long current ramp recording of a PPN
neuron in the presence of SB+TTX+MEC+CAR (red record, top). Note
that this cell was recorded after persistent exposure to CAR (>20 min of
exposure). Below is the record of the same neuron showing that
oscillations were blocked after adding ω-Aga (200 nM) to the extracellular
solution (n=5; gray record, bottom). These recordings confirm that
P/Q-type calcium channel-mediate oscillatory activity in PPN neurons was
induced by persistent activation by CAR. (C) Bar graph showing the mean
frequency of oscillatory activity in the presence of SB+TTX, the nicotinic
receptor blocker MEC, persistent exposure to CAR (red column), and in
the presence of SB+TTX+CAR and non-specific cholinergic antagonist
ATR (blue column). Note that the mean oscillatory frequency of PPN
neurons was significantly higher during persistent exposure to CAR
compared to the condition with ATR in the extracellular solution. (D)Wide
field photomicrograph of the region of the PPN showing the recording
electrode (arrow). Anterior is to the left, posterior to the right, with the
fibers of the superior cerebellar peduncle (SCP) visible ventral to the
recording pipette within the PPN pars compacta, which is located
immediately dorsal to the posterior end of the peduncle. This was the
region selectively sampled, and every cell identified as to PPN cell type. [In
(C): ***p<0.001; calibration bar in (D): 400µm; abbreviations: CAR,
carbachol; SB, synaptic blockers; TTX, tetrodotoxin; MEC, mecamylamine;
ATR, atropine; ω-Aga, agatoxin].
in the power spectra. However, 30 s protocols were not practical
for pharmacological experiments due to their detrimental effect
on the overall health of the neurons when applied for prolonged
periods.
ACUTE VS. PERSISTENT EFFECTS OF CAR ON THE OSCILLATORY
ACTIVITY OF PPN NEURONS
Release of the neurotransmitter acetylcholine (ACh) by the RAS
indirectly leads to cortical fast EEG activity and arousal (22–25).
ACh plays an important role in communication between nuclei
of the RAS, particularly between the PPN and Pf. Both nuclei
are known to receive the cholinergic afferents (26, 27). In our
previous studies, we showed that both PPN and Pf cells have
similar mechanisms involving high threshold, voltage-dependent
calcium channel-mediated gamma oscillations that can increase
in frequency under persistent application of CAR (30µM) (3,
28). During membrane potential recordings in PPN neurons
(in the presence of synaptic blockers, TTX, and MEC), acutely
applied CAR had a blocking effect on high-threshold oscillations
within 2–3 min after bath application. Figure 1A is an example
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of a representative ramp-induced membrane potential oscillation
observed in a PPN neuron in the presence of synaptic blockers,
TTX, and MEC (left record, black). After only 3 min of acute expo-
sure to CAR, oscillations were eliminated (middle record, red).
However, adding atropine (ATR, 10µM) to the extracellular solu-
tion antagonized the effects of CAR on oscillatory activity of the
same PPN neuron. ATR reversed the blocking effect of CAR, and
oscillations returned to the levels prior to the addition of the CAR
(right record, blue; the same results were observed in five PPN
neurons). The effects of ATR suggest the presence of a fast and
reversible acute muscarinic modulation of PPN oscillatory activity.
We previously reported thatω-Agatoxin-IVA (ω-Aga, a specific
P/Q-type calcium channel blocker, 200 nM) blocked the oscilla-
tory properties of PPN neurons (3). Here, we show that P/Q-type
calcium channels play a central role in CAR-mediated persistent
effects since ω-Aga blocked the increase in frequency of oscilla-
tions induced by CAR (n= 4). Figure 1B shows a control current
ramp recording after persistent (20 min) exposure to CAR (red
record), and the blocking effect of ω-Aga (gray record) 10 min
later in the same representative PPN neuron.
Moreover, we compared the mean frequency of PPN
oscillations under the persistent influence of CAR, n= 12
(SB+TTX+MEC, see above) against the mean frequency under
the persistent effect of CAR and ATR, n= 5 (SB+TTX present
in the extracellular solution). Statistical comparison showed that
the CAR group without ATR (41± 1 Hz, red bar) had significantly
higher frequency of oscillation compared to the CAR group with
ATR in the extracellular solution (25± 2 Hz, blue bar) (One-way
ANOVA; df= 16, t =−7.1, p< 0.001). These results suggest that
long lasting activation of muscarinic receptors induced higher
frequency of oscillations in the PPN.
ACUTE APPLICATION OF CAR BLOCKED OSCILLATORY ACTIVITY IN PPN
NEURONS THROUGH M2 MUSCARINIC RECEPTORS
We then determined what subtype of muscarinic cholinergic
receptor is responsible for the blockade of the oscillatory activ-
ity in PPN neurons. Basically, one of the two or both major
muscarinic receptors described in the PPN [M1 and M2; Ref.
(11)], might be blocking oscillations when activated by CAR. We
first tested the role of M1 receptors. To the extracellular solu-
tion containing synaptic blockers and TTX, we added MEC (to
block nicotinic receptors), and methoctramine (MTO to block
M2 muscarinic receptors). We ran ramp protocols to measure the
responsiveness of the cells, as well as its steady state oscillatory
activity. After 10 min, CAR was added to the extracellular solu-
tion, and we recorded 1 s ramps every minute. An example of this
protocol appears in Figure 2A (n= 7). The recording on the left
(black record) taken 2 min after adding MTO shows the oscilla-
tions induced, while the recording on the right (red record) shows
that 14 min after the addition of MTO and 2 min after the addi-
tion of CAR (which would normally block oscillations as shown
in Figure 1) had no effect on the induced oscillations. The power
spectrum of these recordings (far right side) indicates that there
was no shift in the frequency or any blocking effect of the oscilla-
tions, even 12 min after CAR exposure (One-way ANOVA; df= 13,
t = 0.17, p= 0.87). A small decrease in the power of the oscilla-
tions was probably due to a partial rundown of calcium currents,
which is to be expected during whole-cell recordings (Figure 2A,
right, compare black/MTO vs. gray MTO+CAR line). The results
suggest that CAR did not block the oscillations via M1 muscarinic
receptor activation.
To determine if M2 muscarinic receptors were in fact responsi-
ble for mediating the acute CAR-dependent blocking effect of the
oscillations, we used the same extracellular solution as described
above except for the addition of pirenzepine (PIR, a M1 mus-
carinic receptor blocker). By blocking M1 receptors, responses to
CAR could be attributed to M2 receptors. Under these conditions,
the blocking effect of CAR was immediate (Figure 2B; n= 8).
The recording on the left (black record) shows induced oscilla-
tions 1 min after adding PIR, but the recording on the right shows
that the addition of CAR (gray record) eliminated the oscillations
within 3 min of adding CAR. The power spectrum of the record-
ings (far right side) showed a complete blockade of the oscillations
after only a few minutes of exposure to CAR (compare black/PIR
vs. gray/PIR+CAR line). These results suggest that CAR blocks
the oscillations completely through M2 receptors, with no trace
of persisting oscillations indicative of an exclusive role of M2
receptors.
In addition, we showed that oscillations were not blocked by
CAR when all of the cholinergic blockers (MEC that blocks nico-
tinic receptors, MTO that blocks M2 muscarinic receptors, and PIR
that blocks M1 muscarinic receptors) were present in the extracel-
lular solution (Figure 2C; n= 4). The recording on the left (black
record) in the presence of MEC+MTO+PIR manifested oscilla-
tions, which were not affected by the addition of CAR in the right
recording (gray record). The power spectrum from a representa-
tive recording in Figure 2C shows no shift in the frequency even
10 min after the cell was exposed to CAR. The graph on the far
right side of Figure 2C shows that there was no significant dif-
ference in the frequency of oscillations before (26± 2 Hz, black
bar, n= 4) compared to after CAR (26± 1 Hz, gray bar, n= 4) in
an extracellular solution containing all of the cholinergic block-
ers (One-way ANOVA; df= 7, t = 0.24, p= 0.82). These results
suggest that acute activation of M2 muscarinic receptors blocked
beta/gamma oscillations in PPN neurons, and that no portion of
the oscillations remained that could implicate M1, M3, or M4
receptors in this effect.
M2 MUSCARINIC RECEPTORS MEDIATED THE PERSISTENT
CAR-INDUCED SHIFT IN THE FREQUENCY OF PPN OSCILLATIONS
We tested the role of M2 receptors using pirenzepine (PIR, 10µM),
after 20 min of CAR application (i.e., CAR-mediated persistent
effect). Figure 3A shows an example of membrane oscillations
recorded during 1 s long ramps in the presence of CAR+PIR
(n= 11). The power spectrum on the right shows the frequency
of oscillations to be 33 Hz, in the gamma range. In contrast,
cells recorded in a similar extracellular condition, except that
the M1 receptor blocker PIR was replaced with the M2 receptor
blocker MTO, recordings showed reduced gamma band oscilla-
tions induced by 1 s long ramps during exposure to CAR+MTO
(Figure 3B; n= 7). The power spectrum of this record showed a
PPN neuron with large amplitude oscillations in the beta range
(21 Hz), and almost no gamma band activity (Figure 3B, right).
Furthermore, when we added all of the cholinergic blockers
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FIGURE 2 | Acute effect of CAR on M1 and M2 muscarinic receptors in
the PPN. (A) Representative membrane potential oscillations recorded during
1 s long ramps in the presence of SB+TTX+MEC, and the M2 muscarinic
receptor blocker MTO (left record, black). Adding CAR to the extracellular
solution had no effect on the oscillatory behavior of PPN cells, even after
12 min of exposure (right record, gray). The power spectrum of these
recordings (right side) shows that there was no shift in the frequency of
oscillations after acute exposure to CAR. (B) Representative membrane
oscillations obtained during 1 s long ramps in the presence of
SB+TTX+MEC and M1 muscarinic receptor blocker PIR (left record, black).
Adding CAR to the extracellular solution blocked the oscillations after 7 min
(right record, gray). The power spectrum of these recordings (right side)
shows that acute exposure to CAR completely blocked the oscillations acting
through M2 muscarinic receptors. (C) Representative membrane oscillations
recorded during 1 s long ramps in the presence of SB+TTX and all the
cholinergic blockers MEC+MTO+PIR (left record, black). Addition of CAR to
the extracellular solution had no effect on the oscillations (left record, gray).
The power spectrum of these records shows no shift in frequency after
exposure to CAR (middle). The bar graph (right side) shows the mean
frequency of oscillations before and after acute exposure to CAR in the
presence of SB+TTX+MEC+MTO+PIR. Note that there was no statistical
difference in the mean of frequency before (black column, n=4) vs. after
(gray column, n=4) addition of CAR to the extracellular solution in the
presence of nicotinic and muscarinic blockers. (Abbreviations: CAR,
carbachol; SB, synaptic blockers; TTX, tetrodotoxin; MEC, mecamylamine;
MTO, methoctramine; PIR, pirenzepine).
mentioned above (MEC, PIR, and MTO) to the extracellular
solution with synaptic blockers and TTX (Figure 3C; n= 5),
the cells oscillated at lower (beta) frequencies, that were similar
to those previously reported (3). Statistical analysis showed that
PPN cells oscillated significantly faster under persistent applica-
tion of CAR (Figure 3D) when only M2 receptors were available
(MEC+PIR+CAR, 40± 1 Hz, black bar, n= 11), compared to
when only M1 receptors were available (MEC+MTO+CAR,
23± 1 Hz, striped bar, n= 7) (One-way ANOVA; df= 17, t = 8.7,
p< 0.001). These data indicate that persistent activation of M2
muscarinic receptors will trigger the activation of intracellular
second messengers that ultimately affect calcium channels respon-
sible for mediating gamma frequency oscillatory activity. We
then undertook studies to identify the intracellular mechanisms
underlying this phenomenon.
EFFECT OF CAR ON CALCIUM CHANNELS IN THE PPN MEDIATED BY A
VOLTAGE-INDEPENDENT G-PROTEIN MECHANISM
It has been demonstrated that membrane-delimited inhibition of
voltage-dependent calcium channels is affected by Gβγ subunits
of neurotransmitter activated G-proteins (12–16). In particular,
CAR has been described by others to reduce calcium currents
through a membrane-delimited fast mechanism (17, 29, 30). We
employed a three-pulse protocol, previously used in other mod-
els, to study G-protein mediated modulation of calcium currents
(Figure 4A, PROTOCOL). Using the appropriate conditions to
record only calcium currents (3), the protocol consisted of a test
pulse to 0 mV (pre-pulse to test the effects on calcium currents
when G-proteins are bound) followed by a strong depolarizing
step to+50 mV (which at least partially displaces G-protein bind-
ing), a brief return to the holding potential of−50 mV, and finally,
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FIGURE 3 | Persistent effect of CAR on M1 and M2 muscarinic
receptors in the PPN. (A) Representative membrane potential oscillations
recorded during a 1-s long ramp (black record on the left) in the presence
of SB+TTX+MEC+persistent CAR and PIR. Note the higher frequency
of oscillations due to M2 muscarinic receptors being activated. The power
spectrum of this recording (right side) shows oscillations at gamma
frequency. (B) Representative membrane potential oscillations recorded
during a 1-s long ramp (black record on the left) in the presence of
SB+TTX+MEC+CAR and MTO. Note slower oscillatory activity in this
cell due to M1 muscarinic receptors being activated and M2 receptors
being blocked. The power spectrum of this recording (right side) shows
oscillations in the beta frequency range, and reduced gamma band activity.
(C) Representative membrane oscillations recorded during 1 s long ramp
(black record on the left) in the presence of all synaptic blockers including
all the cholinergic blockers (MEC+MTO+PIR). The power spectrum on
the right side shows oscillatory activity in the beta range, similar to the
frequencies observed in the experiment described in (B). (D) Bar graph
showing the mean frequency of membrane potential oscillations for the
cells recorded under persistent exposure to CAR where one group had
only M1 receptors activated (striped column, n=7), and the other group
had only M2 receptors activated (black column, n= 11). Note that both
groups of cells were recorded under the same conditions
(SB+TTX+MEC), except for the specific M1 vs. M2 receptor blockers
(***p< 0.001; abbreviations: CAR, carbachol; SB, synaptic blockers; TTX,
tetrodotoxin; MEC, mecamylamine; MTO, methoctramine; PIR,
pirenzepine).
another test pulse to 0 mV (post-pulse, which tests the effects on
calcium currents when G-proteins are at least partially unbound).
When a given receptor agonist reduces the amplitude of the pre-
pulse more than the post-pulse, a voltage-independent G-protein
mechanism underlies such reduction in calcium currents. On
the contrary, when a similar inhibition is observed at both test
pulses, then a voltage-dependent mechanism can be described.
Here, in the presence of the synaptic blockers, TTX, and MEC,
the total calcium current (ICa) observed after the post-pulse (I2)
was always (n= 24 neurons) of lower amplitude than the one
observed after the pre-pulse (I1), yielding a I2/I1 ratio<1 in every
PPN neuron studied (Figure 4B, black record). Bath application of
ω-CgTX+ω-Aga fully eliminated the ICa observed during three-
pulse protocol (n= 5 PPN neurons, data not shown), suggesting
that the ICa was generated entirely by P/Q-type calcium channels.
Carbachol (30µM) reduced the total amplitude elicited by both
pulses and showed apparent slower kinetics of the ICa without
affecting calcium current amplitude I2/I1 ratios when compared to
control condition (Figure 4B, gray record). The effect of CAR was
prevented after adding GDP-β-S to the intracellular pipette solu-
tion (see Materials and Methods; Figure 4C). The total blocking
effect of CAR (Figure 4E, solid bar) was significantly reduced when
either intracellular GDP-β-S (Figure 4E, open bar), or extracellular
muscarinic receptor antagonists were used (MEC+MTO+PIR,
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FIGURE 4 | Carbachol-mediated voltage-dependent G-protein
modulation of voltage-gated calcium currents in PPN. (A)Three-pulse
protocol (see Materials and Methods) used to study the voltage
dependence of G-protein modulation of calcium currents (ICa) in PPN
neurons. (B) In the presence of synaptic receptor blockers (SB:
GBZ+STR+AP5+CNQX), TTX, and MEC, calcium currents (ICa; black
record) were reduced in amplitude when the three-pulse protocol was
applied. Indeed, the ICa observed after the second 0 mV pulse (I2) was
always of lower amplitude than the one observed after the first pulse (I1),
yielding a I2/I1 ratio <1 in all neurons recorded. Interestingly, CAR (30µM)
reduced the total amount of current during both pulses without affecting
calcium current amplitude in I2/I1 ratios (gray record). (C)The effects of
CAR were prevented in recordings with GDP-β-S in the intracellular solution
(1 mM). Note that the black record (before CAR) was similar to the gray
record (after CAR). (D)The addition of cholinergic receptor antagonists also
reduced the response to CAR. (E)The effect of CAR (solid column) was
significantly reduced when either intracellular GDP-β-S (open column) or
extracellular muscarinic receptor antagonists (M2 antagonist
methoctramine-MTO+M1 antagonist pirenzepine-PIR) (hatched column)
were used. (F) Calcium current I2/I1 ratio values (%) were unchanged by
CAR under any of the experimental conditions. These results suggest that
CAR reduced calcium currents through activation of M2 muscarinic
receptors that activate G-proteins. (Abbreviations: CAR, carbachol; SB,
synaptic blockers; TTX, tetrodotoxin; MEC, mecamylamine; MTO,
methoctramine).
Figure 4D ICa before and after CAR; Figure 4E, hatched bar). Cal-
cium current I2/I1 ratio values (%) were unchanged by CAR under
all experimental conditions (Figure 4F). These results suggest that
CAR reduced calcium currents through activation of M2 mus-
carinic receptors that activate G-proteins via a voltage-dependent
mechanism.
FIGURE 5 | Carbachol-mediated voltage-dependent G-protein
modulation of P/Q-type voltage-gated calcium currents in PPN. (A)
Three-pulse protocol used to study the voltage dependence of G-protein
modulation of calcium currents (ICa) in PPN neurons after blocking N-type
channels with ω-conotoxin-GVIA 2.5µM. In the presence of synaptic
receptor blockers (SB: GBZ+STR+AP5+CNQX), TTX, MEC, and
ω-CgTX-GVIA, calcium current density (ICa; pA/pF, black record) was reduced
in amplitude by CAR (gray record) when the three-pulse protocol was
applied as described in Figure 4. (B) CAR (30µM) reduced the total amount
of current density after the first pulse (before CAR black column, after CAR
gray column; Mann–Whitney Rank Sum Test, p<0.001). (C)Time course of
activation (τON) and deactivation (τOFF) of calcium currents, obtained after
fitting individual currents to the function y = y 0 + a×exp (−[−Time
(ms)/τ(ON or OFF)). The effects of CAR on time course were not significantly
different (Kruskal–Wallis ANOVA, H = 4.33, p=0.23). (Abbreviations: CAR,
carbachol; SB, synaptic blockers; TTX, tetrodotoxin; MEC, mecamylamine).
We then studied the effects of CAR on P/Q-type calcium
channels, which are the main high-threshold calcium channels
involved in PPN oscillatory activity [i.e., after blocking N-type
channels with ω-conotoxin-GVIA 2.5µM; Ref. (3)]. After bath-
applying CAR for >20 min, P/Q-type mediated ICa showed
apparently slower activation and deactivation time courses for
both the pre-pulse and post-pulse compared to the ω-CgTX-
GVIA condition (Figure 5A, τON and τOFF arrows, respectively).
In addition, CAR reduced ICa density (pA/pF) from −71± 5
to −41± 3 pA/pF (Figure 5B, Mann–Whitney Rank Sum Test,
p< 0.001). However, mean current density values observed after
CAR in the absence or presence of ω-CgTX-GVIA were not sig-
nificantly different (CAR: 17± 5 pA/pF, n= 9; CAR+ω-CgTX-
GVIA: 29± 3 pA/pF; Student’s t -test, Kruskal–Wallis ANOVA,
H = 3.6, p= 0.06). No significant differences were observed when
comparing τON/τOFF values (Figure 5C, Kruskal–Wallis ANOVA,
H = 4.33, p= 0.23). These results suggest that the effects of CAR
in reducing oscillations was entirely through P/Q-type calcium
channels.
We then examined the effects of GDP-β-S on the oscilla-
tory activity of PPN neurons. We used an extracellular solution
containing SB, TTX, MEC, and PIR. GDP-β-S was adminis-
tered intracellularly in the pipette. Our results show that the
GDP-β-S (1 mM) blocked oscillatory activity, on average, within
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FIGURE 6 | GDP-β-S blocks oscillatory activity in PPN neurons.
(A) Representative membrane potential oscillation recorded during 1 s ramp
immediately after rupturing the membrane, in the presence of
SB+TTX+MEC+PIR (left record, black). Note the blocking effect of GDP-β-S
on the oscillations in the same neuron after 10 min (right record, gray).
(B) Power spectrum of the records in (A) showing elimination of gamma band
oscillations by GDP-β-S. (C) Representative membrane potential oscillation in
the presence of SB+TTX+MEC+PIR+CAR following rupturing the
membrane (left record, black). Note that activation of G-proteins by GTP-γ-S
did not decrease or further increase the frequency of oscillations (right record,
gray). (D) Power spectrum of the records in C showing that high frequency
oscillation frequency remained similar before (black line) vs. after (gray line)
GTP-γ-S. (Abbreviations: CAR, carbachol; SB, synaptic blockers; TTX,
tetrodotoxin; MEC, mecamylamine; PIR, pirenzepine).
6.8± 0.7 min (n= 7) after gaining access to the intracellular com-
partment (Figure 6A, black record immediately upon patching
but before GDP-β-S diffused into the cell, gray record 10 min after
patching and GDP-β-S had diffused into the cell). The mean fre-
quency of the oscillations for these cells was 27± 2 Hz before they
were blocked by the GDP-β-S (Figure 6B power spectrum, com-
pare black pre-GDP-β-S vs. gray post-GDP-β-S line). These results
show that G-proteins directly affect voltage sensitive P/Q-type
calcium channels responsible for the oscillatory activity in PPN
neurons. In addition to blocking PPN oscillations with GDP-β-S,
we measured the frequency of PPN oscillations by activating G-
proteins with GTP-γ-S (0.4 mM). This agent is known to reversibly
activate G-proteins (31, 32). We used an extracellular solution
containing SB, TTX, MEC, PIR, and CAR. GTP-γ-S was adminis-
tered intracellularly through the pipette (like GDP-β-S). We waited
∼10 min for the GTP-γ-S to diffuse into the cell before we induced
oscillations using current ramps. The first ramp was considered
as minute 0 and a single ramp was recorded every minute for
up to 35 min (Figure 6C). The power spectrum of these records
shows that GTP-γ-S did not further increase the frequency of
oscillations (Figure 6D). Over the extended period of recording,
a gradual decrease in the amplitude of oscillations was observed
(Figure 6D). However, this was probably due to intracellular run-
down of ICa under these protocols and not due to GTP-γ-S, since
we have observed comparable results in our control cells without
GTP-γ-S. Our results showed that the mean frequency of PPN
oscillations in the presence of intracellular GTP-γ-S (38± 1 Hz;
n= 7) was not significantly different from the frequencies reported
under persistent activation of M2 cholinergic receptors (40± 1 Hz;
n= 11) (Figure 1C) (One-way ANOVA; df= 17, t = 6.7, p= 0.6).
We conclude that current ramp-induced PPN oscillations did not
show an increase in frequency, even after G-proteins had been
activated by GTP-γ-S. It is possible that these cells had reached
their plateau of activation after the persistent or long duration
application of CAR.
DISCUSSION
These results show that, (a) persistent activation of muscarinic M2
muscarinic receptors caused the increase in oscillatory frequency
previously shown in PPN neurons (3), and (b) an intracellular
mechanism involving voltage-dependent activation of G-proteins
mediated this increase in oscillatory frequency. That is, G-protein
activation apparently changed both the kinetics and inactivation
of P/Q-type calcium channels, suggesting that G-protein pathways
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are necessary for maintaining gamma band frequency oscillations
in the PPN. This is the first time such physiological characteristics
have been described in PPN neurons. Moreover, we also describe
a dual effect of CAR (30µM) (acute vs. persistent) on PPN oscil-
lations. The significance of these findings is amplified in light of
the recent discovery of similar oscillatory mechanism in the Pf
nucleus, through which PPN projections are relayed throughout
the cortex. PPN neurons show increased firing during waking and
paradoxical sleep (33), while lesions of the PPN reduced or elimi-
nated paradoxical sleep (34). The accumulated evidence from our
studies suggests that the PPN nucleus could play an important
role in maintaining gamma band activity during waking and REM
sleep.
Gamma band activity is characterized by high frequency oscil-
lations (>30 Hz), which are thought to represent the mechanism
for binding patterns of activity among distant neuronal groups
into conscious perception (35–39). Gamma band activity has been
described in cortical (40, 41), hippocampal (42), and cerebellar
neurons (43). In our previous study, we identified the ionic chan-
nels responsible for high frequency oscillations in PPN neurons
(3). We demonstrated that mainly P/Q-type, and to a lesser extent,
N-type calcium channels mediated the rising phase, and delayed
rectifier-like potassium channels mediated the falling phase of
current ramp-induced oscillations (3). Our results suggested that
these calcium channels were located in dendritic compartments
and, in order to be open, we had to depolarize the soma to around
−20 mV or beyond. Using longer 30 s current ramps, we were
able to steadily depolarize the membrane and detect oscillations
at ∼−40 mV membrane potential at the cell body. Thus, ionic
channels necessary for oscillations in the PPN can be recruited
during long lasting gradual depolarization, even in the absence of
APs (i.e., in the presence of TTX), which further confirmed that
current ramps are a useful tool for in vitro studies of physiological
characteristics of ionic channels in distal dendrites.
ACUTE EFFECT OFF CAR
Carbachol activates both types of cholinergic receptors: mus-
carinic (metabotropic), and nicotinic (ionotropic) (2, 11, 19, 27).
The most abundant receptor type in the PPN is the M2 muscarinic
receptor, which is Gi-protein coupled. M2 receptors are known to
hyperpolarize the cell membrane by increasing membrane con-
ductance for potassium ions while reducing calcium currents (44).
Activation of M1 receptors has been reported to decrease mem-
brane conductance by blocking potassium currents (6). In our
study, we demonstrated that acute application of CAR reversibly
blocked PPN oscillations. We speculate that temporary membrane
hyperpolarization, caused by M2 receptor activation, is a possible
explanation for the acute effect of CAR on the oscillatory activity
in PPN neurons. Furthermore, blockade of G-protein activation
by GDP-β-S disrupted the generation of oscillations in the PPN,
suggesting that normal turnover of G-proteins is required to gener-
ate and sustain such oscillations. In the dendrites of hippocampal
neurons, CAR has been shown to modulate calcium entry and
intracellular [Ca2+] by activating signaling pathways linked to
muscarinic receptors (45). Here we show that acute CAR appli-
cation can block P/Q-type calcium channel-mediated oscillations
in the PPN through M2 muscarinic receptors, and assume that, on
a functional basis, brief, or phasic cholinergic input to PPN cells
leads to an inhibition of high frequency oscillations.
PERSISTENT EFFECT OF CAR
In this study, we showed that P/Q-type calcium channels are
responsible for the generation of PPN high frequency oscilla-
tions under persistent exposure to CAR. A specific P/Q-type Ca2+
channel blocker abolished oscillatory activity in the PPN. There-
fore, we conclude that CAR did not change the types of channels
that mediate high frequency oscillations, only their properties.
In our previous study, we showed that persistent exposure to
CAR did not change the amplitude of PPN oscillations com-
pared to non-CAR conditions (3). We speculate that the number
of Ca2+/K+ channels involved in this oscillatory activity did not
change after persistent application of CAR. However, the fre-
quency of these oscillations did increase. This increase in fre-
quency of oscillations indicates that CAR changed the kinetic
properties of these channels. More specifically, we demonstrated
that muscarinic and not nicotinic receptors are responsible for
the increase in oscillatory frequency in PPN neurons. One of
the main goals of this study was to identify which muscarinic
receptors are responsible for such behavior. Our data showed
that M2 (Gi-protein coupled) receptors can effectively block cal-
cium channel-mediated oscillations, and also increase the fre-
quency of oscillations by activating intracellular mechanisms.
This dual effect of the M2 muscarinic receptor has never been
reported in the PPN nucleus. We assume that continuous cholin-
ergic activation of the PPN through the M2 receptors plays
a key role in maintaining high frequency activity among PPN
neurons.
G-PROTEINS
Carbachol reduced calcium currents in PPN neurons as pre-
viously described in other cell types (17, 29, 30). Indeed, it
has been demonstrated that membrane-delimited inhibition of
voltage-dependent calcium channels is affected by Gβγ subunits
of neurotransmitter activated G-proteins (12–16). In our hands,
no oscillations were observed in the presence of GDP-β-S, sug-
gesting that availability of G-proteins is key to generating high
frequency oscillations in the PPN. Using a three-pulse protocol
extensively used by other authors (14–16), we found that CAR
reduced calcium current amplitude of the pre-pulse more than the
post-pulse, suggesting a voltage-dependent G-protein mechanism.
In addition, CAR slowed the kinetics of the ICa without affecting
calcium current amplitude in I2/I1 ratios. The effect of persistent
CAR on calcium currents was prevented after adding GDP-β-S,
and modulated similar effects on calcium currents only mediated
by P/Q-type calcium channels. It is important to emphasize that
calcium current density values after CAR were similar in the pres-
ence or absence ofω-CgTX-GVIA. This novel result might explain
why the persistent CAR effect did not induce a total blockade
of oscillations. Partial blockade of P/Q-type channels and slower
activation/deactivation kinetics than in control conditions would
provide a mechanism for inducing faster frequencies of oscilla-
tions in the presence of CAR. In addition, G-protein modulation
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of potassium channels might also provide the faster membrane
potential repolarization necessary to sustain higher frequencies of
oscillations. Further experiments are needed to further support
this hypothesis.
LIMITATIONS
There are some limitations in this study that need to be recog-
nized. First, we conducted our experiments on neonatal neurons
in PPN nucleus (9–12 days). This age corresponds to the largest
developmental decrease in REM sleep in rats. Although these data
can give us an idea about the physiological properties of these neu-
rons early in the development of the animal, we do not know how
CAR will affect the oscillatory activity of fully developed adult
neurons. Extensive myelination of neurons during development
(>14 days) and in adulthood, especially in the brainstem, renders
patch clamping of these neurons extremely difficult. Therefore,
our conclusions regarding the significance of cholinergic mod-
ulation of RAS oscillatory activity needs to be considered with
caution until these data are confirmed in adult animals. Another
limitation is that our study was conducted on brain slices, which
do not exhibit sleep-wake cycles, or perform other physiological
functions, like movement. Therefore, it is difficult to link single
cell activity of these cells to their functions in vivo. Future exper-
iments, first in whole populations in vitro and then in vivo could
give us a better understanding of mechanism behind gamma band
activity in the RAS. Ultimately, more experiments are needed to
confirm our findings, however, the results described here provide
novel insights into the electrophysiological properties of neona-
tal PPN neurons, and a role for the cholinergic system in the
propagation of high frequency oscillations between the nuclei of
the RAS.
FUNCTIONAL AND CLINICAL IMPLICATIONS
The implications of these results are significant. The marked dif-
ferences between the manifestations of oscillations in PPN cells
during acute vs. persistent exposure to CAR may be related to the
presence of short duration/phasic vs. long duration/tonic cholin-
ergic input. That is, short duration bouts of cholinergic input to
PPN neurons may tend to block their capacity to oscillate at high
frequencies, however, under persistent, long duration, or tonic
cholinergic influence, PPN neurons could oscillate at higher fre-
quencies, especially in the gamma range. It is not clear if phasic
cholinergic tone is more characteristic of patterns observed during
REM sleep, in which PPN cells burst more, or if tonic choliner-
gic tone is more characteristic of waking, when PPN cells tend to
fire more tonically. The intracellular mechanism behind this effect
appears to be related to G-proteins. The fact that inactivation of
G-proteins with GDP-β-S blocked oscillations, but stimulation of
G-proteins with GTP-γ-S had no effect, suggests that G-protein
binding can plateau, beyond which no blockade of oscillations is
possible. We hypothesize that, under short duration, acute, or pha-
sic exposure to cholinergic input, G-proteins can still bind calcium
channels, slowing their activation. This would reduce or prevent
the induction of high frequency oscillations through P/Q-type
calcium channels. However, under long duration, tonic cholin-
ergic input, G-proteins may be bound to the persistent input,
maximizing their utilization, thereby freeing calcium channels to
become activated at their membrane potential threshold, leading
to sustained gamma frequency oscillatory activity. Much addi-
tional information is needed to support this speculation, which
must remain a working hypothesis.
Clinically, ADHD patients manifest an increase in slow wave
(delta, theta), and a decrease in higher frequency (alpha, beta,
gamma) activity (46). Reduced gamma band activity also has
been reported in bipolar disorder (47). Aberrant gamma band
activity and coherence during cognitive tasks or attentional load
have been reported in schizophrenics (48). Several human stud-
ies demonstrated frequency-specific deficits in the coherence and
maintenance of gamma oscillations in patients with schizophre-
nia (49). These disorders manifest symptoms such as hyperarousal,
increased REM sleep drive, and decreased slow wave sleep, among
others, suggesting involvement of the PPN (1). In developing
novel therapies for these disorders, a potential target is the reg-
ulation of voltage-dependent P/Q-type calcium channels leading
to high frequency activity through a permissive mechanism of
G-protein occupation by continuous cholinergic input. Dysreg-
ulation at any point in this complex mechanism could account
for some or all of the sleep-wake symptomatology in some or all
of these disorders, highlighting the potential importance of the
findings described.
In summary, the effect of CAR on PPN oscillatory activity is
mediated by a G-protein voltage-dependent partial reduction of
P/Q-type calcium current amplitude. These novel results support
the idea that both P/Q-type channels and G-protein pathways are
needed in order to sustain high frequency oscillations in PPN
neurons. Moreover, these results suggest that persistent choliner-
gic input creates an active mechanism that allows the fine tuning
of P/Q-type calcium channel-mediated oscillations.
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